Active Not Recruiting NA INTERVENTIONAL 2-arm NCT05810051

Exercise and Coronary Microvascular Disease (ExerciseCMD)

Effects of a Cardiac Rehabilitation Program on Health-related Quality of Life in Patients With Coronary Microvascular Disease.

Sponsor: Abbott Medical Devices

Conditions Coronary Microvascular Disease

Interventions Cardiac rehabilitation

Updated 7 times since 2023 Last updated: Jan 16, 2026 Started: Jul 31, 2023 Primary completion: Apr 15, 2026 Completion: Oct 15, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05810051, this NA trial focuses on Coronary Microvascular Disease and remains ongoing. Sponsored by Abbott Medical Devices, it has been updated 7 times since 2023, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Feb 2026 — Present [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jun 2025 — Feb 2026 [monthly]

Recruiting NA
Feb 2025 — Jun 2025 [monthly]

Recruiting NA
Sep 2024 — Feb 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Dec 2023 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
May 2023 — Dec 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Medical Devices
CoreAalst BV

Data source: CoreAalst BV

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aalst, Belgium